ArticleTechnical innovations & patient support in radiation oncology2026
Evolving person-focused cancer care: the multifaceted benefits of electronic PRO integration and radiation therapist-led follow-up in radiotherapy.
Article in Technical innovations & patient support in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Evidence regarding radiation therapist (RTT)-led follow-up utilising electronic patient-reported outcomes (ePROs) in radiotherapy is scarce. This study evaluated patient and clinician compliance within a novel ePRO-integrated care pathway for prostate cancer (PCa) patients, exploring its impact on communication, involvement, and post-radiotherapy preferences regarding follow-up. Materials and methods: Weekly ePROs were collected via a hospital application during treatment and up to 24 weeks post-radiotherapy. During radiotherapy, RTTs monitored acute toxicity in real-time during weekly ePRO-guided symptom reviews. Compliance was defined as ePROs completed and actively reviewed by the RTT. Patient satisfaction was evaluated using a validated Patient Feedback Form. Four weeks after radiotherapy, patients could choose a structured, RTT-led follow-up consultation. Results: Of 287 enrolled patients November 2020 - March 2024, 248 (86%) completed The Patient Feedback Form. During active radiotherapy, the pooled patient ePRO response rate was 84.8% (1548/1826), and the RTT handling rate was 88.4% (1368/1548 questionnaires). Patient post-treatment response rates remained high at weeks 12 (88.7%) and 24 (82.5%). ePRO integration improved communication with RTTs (93.0%), symptom discussion (95.5%), and control over care (93.0%). Among 177 having the choice of follow-up, 73% selected RTT-led follow-up. In logistic regression models, no sociodemographic or clinical factors predicted follow-up preference, though older age showed a trend for RTT-led follow-up selection (aOR 1.05, 95% CI: 0.99-1.11, Conclusions: The ePRO-integrated workflow fostered an empowering clinical environment with strong patient involvement. Our findings demonstrated high patient and RTT compliance across the digital pathway in a diverse prostate cancer cohort that significantly improved patient-clinician communication with a feasible, preference-driven post-treatment follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.